The stock of Bone Biologics Corp (BBLG) has seen a 2.70% increase in the past week, with a -12.40% drop in the past month, and a -44.58% decrease in the past quarter. The volatility ratio for the week is 8.48%, and the volatility levels for the past 30 days are at 7.57% for BBLG. The simple moving average for the last 20 days is 0.21% for BBLG stock, with a simple moving average of -86.35% for the last 200 days.

Is It Worth Investing in Bone Biologics Corp (NASDAQ: BBLG) Right Now?

There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

The average price estimated by analysts for BBLG is $7.50, which is $36.96 above than the current price. The public float for BBLG is 2.74M, and at present, short sellers hold a 0.34% of that float. The average trading volume of BBLG on November 16, 2023 was 266.34K shares.

BBLG) stock’s latest price update

The stock price of Bone Biologics Corp (NASDAQ: BBLG) has surged by 8.62 when compared to previous closing price of 0.50, but the company has seen a 2.70% gain in its stock price over the last five trading sessions. PennyStocks reported 2023-07-11 that Most traders dream of hitting it big, and penny stocks are some of the most attractive for day traders. It can be any given session where we see at least a handful of cheap stocks under $5 explode.

BBLG Trading at -11.58% from the 50-Day Moving Average

After a stumble in the market that brought BBLG to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.89% of loss for the given period.

Volatility was left at 7.57%, however, over the last 30 days, the volatility rate increased by 8.48%, as shares sank -13.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.96% lower at present.

During the last 5 trading sessions, BBLG rose by +2.70%, which changed the moving average for the period of 200-days by -93.59% in comparison to the 20-day moving average, which settled at $0.5376. In addition, Bone Biologics Corp saw -91.37% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at BBLG starting from Walsh Deina H, who purchase 8,000 shares at the price of $0.64 back on Sep 13. After this action, Walsh Deina H now owns 15,000 shares of Bone Biologics Corp, valued at $5,120 using the latest closing price.

Frelick Jeff, the Chief Executive Officer of Bone Biologics Corp, purchase 9,500 shares at $0.69 during a trade that took place back on Sep 11, which means that Frelick Jeff is holding 17,204 shares at $6,530 based on the most recent closing price.

Stock Fundamentals for BBLG

The total capital return value is set at -58.54, while invested capital returns managed to touch -23.71. Equity return is now at value -102.26, with -69.97 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 3.33.


In summary, Bone Biologics Corp (BBLG) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.